Ablation Frontiers

The company was acquired by Medtronic in 2009 and became part of the company's Cardiac Rhythm Disease Management (CRDM) business.

History

Ablation Frontiers was a venture-backed medical device company based in Carlsbad, California. Founded in 2004, the company focused on developing and commercializing innovative products for the treatment of cardiac arrhythmias. In 2006, Ablation Frontiers received CE Mark to begin marketing its system of catheters and the GENius Radiofrequency (RF) Generator in the European Union to treat supraventricular arrhythmias and for use in atrioventricular node ablation. The company received $21.8 million Series C financing in June 2007, led by the Novartis Venture Fund, to drive clinical development and market expansion for their novel Cardiac Ablation System.

See this press release: http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=1770550&highlight=